Abu Dhabi Health Authority announced its cooperation with Pfizer, AstraZeneca, Roche and GlaxoSmithKline in the fields of medical research.

5 global agreements establish Abu Dhabi as a leading destination for healthcare

The Abu Dhabi Health Authority has provided an appropriate legislative environment that stimulates research and innovation in health care.

From the source

The Department of Health in Abu Dhabi has succeeded in enhancing Abu Dhabi’s position as a leading destination for healthcare in the world, by establishing global partnerships to continue moving towards upgrading the healthcare sector in the emirate, in line with the leadership’s directives aimed at stimulating innovation, clinical research, pharmaceutical industries, and developing world evidence. Reality, digital health, and the establishment of Abu Dhabi’s position as an incubator for life sciences. During the last month, the department signed five agreements with major international companies in the health and pharmaceutical industries, to benefit the knowledge economy of the Emirate and the UAE.

In detail, the department confirmed that the Emirate of Abu Dhabi continues to establish its position as an incubator for innovation in the field of health care regionally and globally, and is moving forward towards providing advanced services, treatments and technologies in health care, to enhance the efficiency and quality of the sector in the emirate, share Abu Dhabi's pioneering experience, and exchange lessons learned with partners from various around the world.

The department and the global pharmaceutical company Pfizer signed a cooperation agreement to enhance research efforts and scientific knowledge in the emirate, by developing specialized training programs for the initial stages of clinical trials, and programs for developing drugs and medicines, in addition to proceeding with the emirate's initiatives aimed at upgrading the digital health system and innovation in The cooperation will also include training 150 clinical researchers over a period of two years, to support the emirate’s plans to develop research cadres, to reach 500 specialized clinical researchers in 2025 through the launch of a number of initiatives and the development of more related partnerships.

The department and the global biopharmaceutical company “AstraZeneca” also signed an agreement to enhance research and development efforts in health sciences, and advance innovation in health services, within the framework of the department’s strategy to ensure that patients receive high-quality health care locally and regionally. The agreement resulted in the cooperation of “G42 Healthcare.” The leading health technology company, headquartered in Abu Dhabi, and a subsidiary of G42 Artificial Intelligence and Cloud Computing in Abu Dhabi, and AstraZeneca to enhance clinical research and diagnostic frameworks in the UAE.

The department and Roche, the world's largest biotechnology company, also signed an agreement to achieve an integrated system of cooperation in the field of personal health care and biopharmaceutical technology, to enrich the future of health care, and support efforts to develop standards for conducting clinical trials, to obtain "real world evidence." » For promising therapeutic solutions, conducting relevant scientific research, and contributing to a comprehensive development of health technology, in accordance with international best practices, in addition to accelerating access to innovative therapeutic and diagnostic solutions to consolidate Abu Dhabi’s position as a center for life sciences innovations, thus enhancing the quality of health and well-being of communities in Abu Dhabi.The Abu Dhabi Department of Health announced the completion of its fruitful cooperation with GlaxoSmithKline, the world leader in the healthcare sector, and the two parties' continuing to enhance ways of cooperation to develop "real world evidence" (RWE), after Abu Dhabi became the first in the world to develop "evidences of the real world". The Real World", based on real data, on the use and efficacy of the innovative drug "Sotrovimab" for the treatment of "Covid-19" in Abu Dhabi.

The cooperation stipulates that Abu Dhabi will rely on its current logistical network to supply and distribute Sotrovimab and its basic medical equipment, in coordination with Rafid Company and Abu Dhabi International Airport. Focuses on epidemiology, vaccines, oncology, and pulmonary diseases.

In addition to the four agreements, Abu Dhabi has strengthened ways of joint cooperation with Belgium, as it is a leading global center in the world of pharmaceutical industries, and the Abu Dhabi Department of Health hosted a delegation from Belgium, and during the visit a cooperation agreement was signed between Belgium and Abu Dhabi, where the parties to cooperation look forward, led by the Abu Dhabi Department of Health. , to establish an air corridor to provide integrated services for the transportation and delivery of pharmaceutical products from their production points to their final destinations. Agreement to host the second edition of the "pharma.aero" logistics program at Khalifa University in Abu Dhabi, from 5 to 9 September 2022.The head of the department, Abdullah Al Hamed, stressed that such important partnerships contribute to strengthening Abu Dhabi’s position as an incubator for innovation in life sciences, and a leading destination for health care in the world, as the emirate is keen to follow the directives of the leadership to attract and consolidate fruitful relations of cooperation, bringing together local institutions with major international companies. in the health sector. He said: "All these efforts fall within our vision based on ensuring the availability of health care services, according to the best levels of quality and efficiency based on international scientific foundations, and employing the latest innovations and promising technologies in health care, to benefit the knowledge economy of the Emirate of Abu Dhabi and the UAE, and the health and safety of communities. around the world.”“All these efforts fall within our vision based on ensuring the availability of health care services, according to the best levels of quality and efficiency based on global scientific foundations, and employing the latest promising innovations and technologies in health care, to benefit the knowledge economy of the Emirate of Abu Dhabi and the UAE, and the health and safety of communities in various regions. around the world".“All these efforts fall within our vision based on ensuring the availability of health care services, according to the best levels of quality and efficiency based on global scientific foundations, and employing the latest promising innovations and technologies in health care, to benefit the knowledge economy of the Emirate of Abu Dhabi and the UAE, and the health and safety of communities in various regions. around the world".

Drone to transport medicines

The Abu Dhabi Department of Health announced its intention to license the use of the latest advanced technologies for unmanned aerial vehicles (UAVs), in the transport and delivery of medical supplies in the health sector in the emirate, as part of the plans to prepare for the fifty years, the UAE strategy for the Fourth Industrial Revolution, and the department's efforts aimed at establishing Abu Dhabi's leading position on the map Global innovation, developing and upgrading healthcare services in the emirate, through the use and employment of the latest innovations and advanced technologies, to build a world-leading health system.

The project is based on developing an advanced delivery system and network using drones, comprising 40 stations to support the health sector during 2022, which will provide transportation and delivery services to various health facilities through a rapid system for emergency cases, working around the clock according to a chain that can be tracked and its updates monitored in real time. The new system will contribute to the speed and ease of transportation of samples and medical supplies, and the management of emergency situations, such as the transportation of urgent medicines, antitoxins, vaccines, etc., which will contribute to reducing occupancy rates in health facilities and enhancing the quality of their outputs.

Abdullah Al Hamed:

 "Abu Dhabi is keen to attract and consolidate fruitful cooperation relations with major local and international institutions in the health sector."

Cooperation with Pfizer includes training 150 clinical researchers to develop research cadres.

Partnering with Roche to develop standards for clinical trials, to obtain “real-world evidence” for promising therapeutic solutions.

Follow our latest local and sports news and the latest political and economic developments via Google news